Statement Of Cash Flows [Abstract]

Biocartis Group NV - Filing #3122956

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
38,826 EUR
59,285 EUR
Interest paid, classified as operating activities
6,027 EUR
6,429 EUR
Cash flows from (used in) operating activities
44,855 EUR
65,716 EUR
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire interests in joint ventures, classified as investing activities
1,000 EUR
0 EUR
Purchase of property, plant and equipment, classified as investing activities
1,569 EUR
3,686 EUR
Purchase of intangible assets, classified as investing activities
368,000 EUR
69,000 EUR
Interest received, classified as investing activities
6,000 EUR
7,000 EUR
Cash flows from (used in) investing activities
5,431 EUR
3,748 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
15,000 EUR
6,000 EUR
Repayments of borrowings, classified as financing activities
26,301 EUR
7,089 EUR
Interest paid, classified as financing activities
73,000 EUR
115,000 EUR
Cash flows from (used in) financing activities
22,463 EUR
1,204 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
27,823 EUR
70,668 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
426,000 EUR
522,000 EUR
Cash and cash equivalents
26,125 EUR
53,522 EUR
123,668 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.